65,437 trials
Ebola
Primary: Geometric Mean Concentrations (GMCs) of Binding Antibody Levels Against the Ebola Virus Glycoprotein (EBOV GP) as Measured by Enzyme-linked Immunosorbent Assay (ELISA)…
Constipation
Primary: Number of Participants With Treatment Success (≥3 Spontaneous Defecations Per Week With no Fecal Soiling — 24; 28 Participants — p=0.399
Uncontrolled Hypertension
Primary: Change in Systolic and Diastolic Blood Pressure (BP) — 140.07; 139.03; 124.18; 128.31 mmHg
Type 2 Diabetes Mellitus · Chronic Kidney Disease · Left Ventricular Diastolic Dysfunction
Primary: Galectin-3 — 9570.91; 9266.7; 9539.21; 8098.78 pg/ml
Hypertension · Blood Pressure · Lifestyle Risk Reduction
Primary: 24-hour Systolic Ambulatory Blood Pressure (mmHg) — 132.59; 133.01; 128.14; 130.69 mmHg
Influenza
Primary: Innate Cell IFNa2a Production — 112.3650; 131.4214; 107.5846; 134.9071 pg/mL
Postoperative Pain
Primary: Brief Pain Inventory-short Form (BPI) Pain Severity Subscale Score — 16.7; 18.1 score on a scale
Hepatitis B
Primary: Number of Participants Achieving Sustained Virologic Response (SVR) — 6; 6; 2; 0 Participants
Cardiac Toxicity · Malignant Neoplasm · Breast Cancer
Primary: Number of Participants Completing the Trial (Exercise Capacity Addendum) — 17; 8 Participants
Type 1 Diabetes Mellitus
Primary: Changes in Gray Matter Volume in the Brain — -4.83; -9.31 centimeters cubed
Diabetic Peripheral Neuropathic Pain · Diabetic Peripheral Neuropathy
Primary: Change From Baseline to Week 4 in the Weekly Average of the Daily Pain Score as Derived From the Subject's Responses on the Pain Intensity Numerical Rating Scale…
Hyperhidrosis
Primary: Change of Hyperhidrosis Disease Severity Measure-Axillary (HDSM-Ax) Score From Baseline to End of Therapy — -1.30; -2.02; -2.09; -2.10 score on a scale
Visual Acuity
Primary: Lid Margin Staining (Part1: Dailies Aqua Comfort Plus) — 1.02; 1.25; 1.45; 1.78 Units on a Scale
Breast Ductal Carcinoma In Situ
Primary: Mean Percent of Nelipepimut-S-specific Cytotoxic T Lymphocyte Response (E75) — 0.09; 0.02 percent of cytotoxic T lymphocytes — p=0.71
Atrial Fibrillation
Primary: Number of Participants With Esophageal Thermal Injury — 8; 1 participants — p=0.02